References
- Babitha PP, Sahila MM, Srinivas Bandaru, et al (2015) Molecular docking and pharmacological investigations of rivastigminefluoxetine and coumarin–tacrine hybrids against acetyl choline esterase. Bioinformation, 11, 378-86. https://doi.org/10.6026/97320630011378
- Bandaru S, Ponnala D, Lakkaraju C, et al (2014). Identification of high affinity non-peptidic small molecule inhibitors of MDM2-p53 interactions through structure-based virtual screening strategies. Asian Pac J Cancer Prev, 16, 3759-65.
- Chanda S, Anuradha N, Srinivas B, et al (2015). An in silico approach for identification of novel inhibitors as a potential therapeutics targeting hiv-1 viral infectivity factor. Curr Top Med Chem, 15, 65-72. https://doi.org/10.2174/1568026615666150112114337
- Cheng F, Li W, Zhou Y, et al (2012). AdmetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model, 52, 3099-105. https://doi.org/10.1021/ci300367a
- Desai SB, Moonim MT, Amarinder KG, et al (2000). Hormone receptor status of breast cancer in India: a study of 798 tumours. Breast, 9, 267-70. https://doi.org/10.1054/brst.2000.0134
- Dunna NR, Kandula V, Girdhar A, et al (2015). High Affinity Pharmacological Profiling Of Dual Inhibitors Targeting Ret And Vegfr2 In Inhibition Of Kinase And Angiogeneis Events In Medullary Thyroid Carcinoma. Asian Pac J Cancer Prev, 16, 7089-795. https://doi.org/10.7314/APJCP.2015.16.16.7089
- Franklin, MC, Carey KD, Vajdos FF, et al (2004). Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer cell, 5, 317-28. https://doi.org/10.1016/S1535-6108(04)00083-2
- Gimanez MA, Drago SR, Bassett MN, et al (2016). Nutritional improvement of corn pasta-like product with broad bean (Vicia faba) and quinoa (Chenopodium quinoa). Food Chem, 199, 150-56. https://doi.org/10.1016/j.foodchem.2015.11.065
-
Hafeez BB, Siddiqui IA, Asim M et al (2008). A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells In vitro and in vivo: involvement of nuclear factor-
${\kappa}B$ signaling. Cancer Res, 68, 8564-72. https://doi.org/10.1158/0008-5472.CAN-08-2232 - Jorgensen WL, Tirado-RJ (2005). Potential energy functions for atomic-level simulations of water and organic and biomolecular systems. Proc Natl Acad Sci U S A, 102, 6665-70. https://doi.org/10.1073/pnas.0408037102
- Kelotra S, Jain M, Kelotra A, et al (2014). An in silico appraisal to identify high affinity anti-apoptotic synthetic tetrapeptide inhibitors targeting the mammalian caspase 3 enzyme. Asian Pac J Cancer Prev, 15, 10137-42.
- Lipinski CA, et al (2004). Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol, 1, 337-41.
- Maunz A, Gütlein M, Rautenberg M, et al (2013). Lazar: a modular predictive toxicology framework. Front Pharmacol, 4, 38
- Nelder JA, Mead R (1965). A simplex method for function minimization. Comput J, 7, 308-13. https://doi.org/10.1093/comjnl/7.4.308
- Ozbay T, Nahta R (2011). Delphinidin inhibits HER2 and Erk1/2 signaling and suppresses growth of HER2-overexpressing and triple negative breast cancer cell lines. Breast Cancer (Auckl), 5, 143-54.
- Park Y, Hyun-Tae S, Hae HJ, et al (2015). Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer. Oncotarget, 6, 32027-38. https://doi.org/10.18632/oncotarget.5184
- Parkin DM, Bray F, Ferlay J, et al (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-56. https://doi.org/10.1002/ijc.1440
- Sahila MM, Babitha PP, Srinivas Bandaru, et al (2015) Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives. Bioinformation, 11, 280-89. https://doi.org/10.6026/97320630011280
- Thomsen R, Christensen MH (2006). MolDock: a new technique for high-accuracy molecular docking. J Med Chem, 49, 3315-21. https://doi.org/10.1021/jm051197e
- Vaidyanathan K, Kumar P, Reddy CO, et al (2010). ErbB-2 expression and its association with other biological parameters of breast cancer among Indian women. Indian J Cancer, 47, 8-15. https://doi.org/10.4103/0019-509X.58852
- Veber DF, Johnson SR, Cheng HY, et al (2002). Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem, 45, 2615-23. https://doi.org/10.1021/jm020017n
- Vogel CL, Cobleigh MA, Tripathy D, et al (2002). Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol, 20, 719-26. https://doi.org/10.1200/JCO.20.3.719